GENE ONLINE|News &
Opinion
Blog

Urothelial Carcinoma
Deals MerckBavencio
Merck Regains Worldwide Rights to BAVENCIO After Parting Ways with Pfizer
2023-03-29
Trials & Approvals Bladder Cancer
Astellas Submits New Drug Application Targeting First ADC Approval for Metastatic Urothelial Cancer in Japan
2021-03-13
Trials & Approvals Bladder Cancer
AstraZeneca Voluntarily Withdraws Checkpoint Inhibitor Approved for Bladder Cancer Indication
2021-02-25
Trials & Approvals Bladder Cancer
Bavencio Bags FDA Approval as First-line Maintenance Treatment for Urothelial Carcinoma
2020-07-05
R&D
ASCO 2020: Maintenance Therapy with Avelumab Post-Chemo Improves Overall Survival of Bladder Cancer Patients
2020-05-29
R&D Antibody-Drug Conjugate
Padcev Keytruda Combo Garners Breakthrough Therapy Designation for Urothelial Cancer
2020-02-20
LATEST
Comparative Analysis of Tirzepatide (Zepbound/Mounjaro) and Semaglutide (Wegovy) for Weight Loss
2025-05-12
Donald Trump’s “Most Favored Nation” Executive Order on Drug Pricing
2025-05-12
Discover Investment Opportunities & Innovation at International Healthcare Week in Hong Kong from May
2025-05-12
The Buffett Paradox: Cola, Happiness, and a Biotech Longevity Enigma
2025-05-11
President to Sign Executive Order on Trade Enforcement Monday Morning
2025-05-11
Trump to Sign Executive Order Linking U.S. Drug Prices to International Levels.
2025-05-11
Podcast Highlights Agile Biopharmaceutical Firms’ Strategies for Navigating Complex Clinical Trials
2025-05-11
READ MORE
EVENT
2025-05-13
ASGCT 28th Annual Meeting 2025
New Orleans, U.S.A.
2025-05-26
2025 Antibody Therapeutic & Frontiers in Biomedical Sciences Conference
Taipei, Taiwan
2025-05-30
ASCO Annual Meeting 2025
Chicago, U.S.A
2025-06-11
ISSCR 2025 Annual Meeting
Hong Kong
2025-06-16
US BIO International Convention
Boston, U.S.A.
SEE MORE
Newsletter

Subscribe to receive updates.

SIGN UP
Facebook
Youtube
Twitter
Linkedin
About
Explore
More
© 2025 GeneOnline
Privacy Policy | Terms of Service
Privacy Policy | Terms of Service
  • Subscribe to our newsletter and dive into the world of biopharma with us.
SIGN UP
x
Scroll to Top